Economics of Research and Surveillance: Value of Information David Hutton.

Slides:



Advertisements
Similar presentations
Trends in Adult Vaccination Coverage Internal for NAIIS Provider Workgroup March Meeting Preliminary Data National Health Interview Survey
Advertisements

Access to Vaccines in LEDCs By Billy Carr. Outline to Vaccines Can be referred to as inoculations or immunization A substance which contains a harmless.
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
بسم الله الرحمن الرحيم. IRAN Vaccination policy for post eradication phase Presented by : A. R.ESTEGHAMATI, MD IRAN EPI Manager.
CDC Director’s Perspective Immunization Program Managers Meeting Thomas R. Frieden, MD, MPH Director, CDC Administrator, ATSDR.
POLIO ERADICATION PROGRAM IN INDIA BY P. K. SAHA , M
Immunization and the Convention on the Rights of the Child What would it take to achieve universal coverage? Daniel Tarantola M.D. Professor of Health.
The Cost Effectiveness of Vaccinating against Lyme Disease Martin I. Meltzer, David T. Dennis, and Kathleen A. Orloski Centers for Disease Control and.
Schneider Institute for Health Policy, The Heller School for Social Policy and Management, Brandeis University Issues in Cost Analysis of Substance Abuse.
Engagement strategies for Montoring & Evaluation Charlotte Colvin MEASURE Regional NTP Workshop New Delhi, India 2 February 2006 MEASURE Evaluation.
HAS 3150 Chapter 10. Infectious Diseases Diseases caused by living microorganisms.
CIDID Polio Modelers at The University of Michigan Epidemiology: Jim Koopman, Marisa Eisenberg, Joe Eisenberg, Christopher Henry, Xinyu Zhang Statistics:
Supporting Routine AND Supplementary Immunization Activities in STOP.
Protecting our Health from Climate Change: a Training Course for Public Health Professionals Chapter 5: Policy Responses to Address the Health Risks of.
Module 5 Recording and monitoring uptake of Inactivated Polio vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Interoperability to Support a Learning Health System HL7 Learning Health Systems Workgroup.
© 2008, Johns Hopkins University. All rights reserved. Documenting the Quick Win The Quick Win Step 1: Formative Step Step 2: Process Activities Step 3:
What is Health Communication?. Learning Objectives Be able to –Define health communication –Identify examples of health communication.
$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.
Application in professional activity of theoretical knowledge and practical skills acquired during residency program Dr. Ion Bîrcă National Center of Public.
Population and Public Health Patricia Taiwo. Introduction Public health focuses on the health of the population and the community as a whole by ensuring.
Health Data Workgroup September 28,  Response to State Health Plan ◦ Develop a roadmap for continuing to build Maine’s health data, analysis and.
Developing Effective Tobacco Policy Tracking Systems Diane Beeson, MBA, Director Alabama Tobacco Prevention and Control Division.
Unit 1 Area of Study 2. An Externality is any effect on a third party that results from economic activities.
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
PORTFOLIO COMMITTEE PRESENTATION Ms. Joyce Mogale (Interim CEO) Prof. Perez (Chair ) Supporting a long and healthy life for all South Africans NHLS ANNUAL.
Combination vaccines (Presented by Dr. Shyama Saikia)
1 Exotic Disease Response Training Introduction to Surveillance.
Progress of Polio Eradication in India, Current Risks & Actions taken on last IEAG report 24 th IEAG, New Delhi 15 March 2012 Dr. Ajay Khera Deputy Commissioner.
Identify a Health Problem Qualitative Quantitative Develop Program -theory -objectives -format -content Determine Evaluation -design -sampling -measures.
Integrating Public Health and Adaptation Kristie L. Ebi, Ph.D., MPH Cities at Risk 28 February 2009.
Health Information Exchange & Public Health Robert J. Campbell, Ph.D. Center for Public Health Statistics and Informatics Ohio Department of Health March.
The Wellness Impact: Enhancing Academic Success through Healthy School Environments Laura Frese, RD, LDN Midwest Dairy Council April 30, 2013.
1 Section 3 The Economics of Markets and Government.
Dr, Janbaz Afridi Deputy Director EPI Khyber Pakhtunkhwa
National Center for Chronic Disease Prevention and Health Promotion
 2007 Johns Hopkins Bloomberg School of Public Health Introduction to Program Evaluation Frances Stillman, EdD Institute for Global Tobacco Control Johns.
Economic, Social and Environmental Benefits Better Planning and Operational Decisions in Water Management Decision Making Capacity and Institutions; Stakeholder.
1 EPI services for migrant populations in Tak province.
National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.
EVALUATION RESEARCH To know if Social programs, training programs, medical treatments, or other interventions work, we have to evaluate the outcomes systematically.
INTRODUCTION TO INFORMATION SYSTEMS FOR IMMUNIZATION SERVICES IPV Global Workshop March 2014.
Using Informatics To Promote Community/Population Health Doris Glenn V. Flores, RN.
1 |1 | Regulatory authority and Immunization programs: a joint work for patient safety Global Vaccine Safety Group Department of Essential Medicines and.
The polio endgame and silent circulation: some related research.
Module 5 Recording and monitoring administration of the Inactivated Polio Vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Polio and Polio Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
Assessment of areas at increased risk for undetected poliovirus circulation in Ecuador Gustavo Dayan, MD Epidemiology Surveillance Division National Immunization.
The PHRplus Project is funded by U.S. Agency for International Development and implemented by: Abt Associates Inc. and partners, Development Associates,
A proposed process for participatory decision on standards of care Daniel Tarantola, M.D., The University of New South Wales, Sydney, Australia IAS Conference,
Economic and development dimensions of NCDs A presentation of the paper: Economic Development and Non-Communicable Chronic Diseases, published in the Global.
Risk factors for human cutaneous anthrax and an enhanced surveillance program of anthrax in livestock, North-West of Bangladesh Regional Training in Animal.
Perspective and Update
Surveillance. Public Health Approach Surveillance What is the Problem ? Problem Risk Factor Identification : What Is the Cause ? Intervention Evaluation.
The Polio Eradication and Endgame Strategic Plan
Family Policy: The Rational Choice Framework
بسم الله الرحمن الرحيم.
Economics of Public Health Nursing
Programme Analysis Planning, Monitoring, and Evaluating Programmes
Stakeholder Consultation
DRC Challenges with Multiple Surveillance Systems
بسم الله الرحمن الرحیم فرآیند رسیدگی به شکایات
When do we make decisions?
Economic Policy.
Surveillance, Monitoring and Evaluation Working Group
Warm-up question Chapter 1 Section 2
Engagement Strategies for Monitoring & Evaluation
Nili Karako Eyal, School of Law, College of Management, Israel
Presentation transcript:

Economics of Research and Surveillance: Value of Information David Hutton

Motivation Policymakers may be interested in evaluating the health and economic costs and benefits of surveillance vs. other actions they may take Researchers want to determine the value of additional surveillance or scientific studies

Stylized Example 1: Surveillance Policy Decision Silent Circulation IPV Only Supplemental OPV Yes No $$$ $ $$

Stylized Example 1: Surveillance Policy Decision Silent Circulation IPV Only Supplemental OPV Yes No Yes No IPV Only Supplemental OPV Policy Decision Silent Circulation Policy Decision IPV Only Surveillance Supplemental OPV

Polio Data Collection Example Cost-effectiveness of sewage treatment monitoring –Policy Actions Monitor Sewage Supplemental OPV Other Policy Actions… –Outcomes: Costs –Monitoring –Vaccination –Disease Health Outcomes (monetized) Trust/Goodwill (monetized)

Stylized Example 2: Understanding Immunity Policy Decision Waning Immunity IPV Only Supplemental OPV Slow-Deep Fast-Shallow Silent Circulation Yes No

Stylized Example 2: Understanding Immunity Policy Decision Waning Immunity Enhanced Surveillance Slow-Deep Fast-Shallow Silent Circulation Yes No AFP Surveillance

Understanding Immunity What would we want to know? –Waning “Speed”? “Depth”? How would we collect that information? What would we do with that information?

Thank You Questions?